We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

51 hedge funds and large institutions have $138M invested in Axcella Health Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 4

280% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 5

174% more capital invested

Capital invested by funds: $50.4M → $138M (+$87.7M)

65% more funds holding

Funds holding: 3151 (+20)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
51
Holders Change
+20
Holders Change %
+64.52%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
24
Increased
19
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$71K +$62.9K +514 New
State of Wisconsin Investment Board
27
State of Wisconsin Investment Board
Wisconsin
$70K +$62.1K +508 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$67K
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$61K
Two Sigma Advisers
30
Two Sigma Advisers
New York
$61K +$53.8K +440 New
LI
31
Leap Investments
Illinois
$58K +$51.4K +420 New
JP Morgan Chase
32
JP Morgan Chase
New York
$41K -$125K -1,022 -77%
Morgan Stanley
33
Morgan Stanley
New York
$36K +$28.9K +236 +814%
AIG
34
American International Group
New York
$32K +$5.99K +49 +26%
Barclays
35
Barclays
United Kingdom
$30K +$13.2K +108 +103%
Acadian Asset Management
36
Acadian Asset Management
Massachusetts
$30K +$26.9K +220 New
Deutsche Bank
37
Deutsche Bank
Germany
$28K +$13K +106 +108%
Bank of America
38
Bank of America
North Carolina
$25K +$14.2K +116 +176%
UBS Group
39
UBS Group
Switzerland
$17K -$29K -237 -65%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$11K +$9.79K +80 New
TRCT
41
Tower Research Capital (TRC)
New York
$11K +$10K +82 New
Legal & General Group
42
Legal & General Group
United Kingdom
$9K +$5.02K +41 +186%
Citigroup
43
Citigroup
New York
$7K -$6.12K -50 -51%
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$4K +$3.92K +32 New
OIA
45
Optimum Investment Advisors
Illinois
$3K +$2.94K +24 New
First Manhattan
46
First Manhattan
New York
$2K +$2.45K +20 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$1.61K -$10.5K -86 -88%
AIP
48
Ameritas Investment Partners
Nebraska
$1K
Osaic Holdings
49
Osaic Holdings
Arizona
$1K +$489 +4 New
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
-$263K -3,075 Closed

AXLA Hedge Fund Activity: Q2 2020 in Review

51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2020, worth a combined $138M — up 174% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AXLA positions and 4 closed out — a net gain of 20 holders — while 19 added to existing stakes and 5 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $18.6M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $263K sold.

  • 51 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2020, up from 31 in Q1 2020.
  • Funds reported $138M of Axcella Health Inc. Common Stock stock for Q2 2020, up 174% quarter-over-quarter.
  • 24 funds opened new Axcella Health Inc. Common Stock positions in Q2 2020 and 4 closed out, a net change of +20 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2020 was Flagship Pioneering, an estimated $18.6M added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2020 was Alyeska Investment Group, an estimated $263K sold.

Based on aggregated 13F filings for Q2 2020.